Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Public ClinicalTrials.gov record NCT05271552. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy And Safety Study of PRN Dosing of BXCL501 Over A 12 Week Period In Subjects With Agitation Associated With Dementia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to determine the safety and efficacy of BXCL501 dosing for episodes of agitation associated with dementia when they occur (given as needed \[PRN\]), for a maximum of 28 doses within a 12-week treatment period.
Study identification
- NCT ID
- NCT05271552
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 151 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2022 (Actual)
- Primary completion
- Apr 21, 2023 (Actual)
- Completion
- Apr 21, 2023 (Actual)
- Last update posted
- Aug 11, 2026
2022 – 2023
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| BioXcel Clinical Research Site | Phoenix | Arizona | 85016 | — |
| BioXcel Clinical Research Site | Long Beach | California | 90806 | — |
| BioXcel Clinical Research Site | Daytona Beach | Florida | 32117 | — |
| BioXcel Clinical Research Site | Lady Lake | Florida | 32159 | — |
| BioXcel Clinical Research Site | Maitland | Florida | 32751 | — |
| BioXcel Clinical Research Site | Miami Lakes | Florida | 33016 | — |
| BioXcel Clinical Research Site | North Miami | Florida | 33161 | — |
| BioXcel Clinical Research Site | Marrero | Louisiana | 70072 | — |
| BioXcel Clinical Research Site | Springfield | Massachusetts | 01103 | — |
| BioXcel Clinical Research Site | Berlin | New Jersey | 08009 | — |
| BioXcel Clinical Research Site | Toms River | New Jersey | 08755 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05271552, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05271552 live on ClinicalTrials.gov.